-

2020 Guide to European CLP Regulations of Nicotine-Containing Products - Modern Oral Admixtures, Heated Tobacco/e-Cigarette Hybrids and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "A Guide to European CLP Regulations" report has been added to ResearchAndMarkets.com's offering.

In Europe, chemical substances are classified according to their toxicity levels. Any that are concluded to be potentially harmful are subject to rules on packaging and labelling.

This report does not aim to provide guidance on every regulation that may apply in all member states of the European Union, rather it will concentrate on an important piece of regulation that may apply to nicotine-containing products such as modern oral admixtures and heated tobacco/e-cigarette hybrids.

CLP regulation is vital to be aware of when placing products on the market, and so a good understanding of this piece of regulation is vital. This bundle report of three individual reports will provide you with a comprehensive overview of the rules within this specific regulation.

Key Topics Covered

Report 1

1 Executive summary

2 Introduction

3 General obligations

4 Assessing the toxicity of nicotine mixtures

5 Rules on warning labels

6 General packaging rules (Article 35)

Report 2

1 Executive summary

2 Introduction

3 General obligation to notify to the C&L Inventory (articles 39-42)

4 Notification to national poison centres (Article 45)

5 A new obligation related to packaging

Report 3

1 Executive summary

2 Introduction

3 Small packaging exception

4 Condition 1: hazard classification

5 Condition 2: shape and form of packaging

6 Condition 3: alternative means of labelling

7 Permissible omission of elements

For more information about this report visit https://www.researchandmarkets.com/r/wsga5h

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom